###begin article-title 0
Conservation of Nef function across highly diverse lineages of SIVsmm
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 12 41 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 114 129 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 131 134 <span type="species:ncbi:9531">SMs</span>
###xml 188 194 <span type="species:ncbi:9606">humans</span>
###xml 438 444 <span type="species:ncbi:9606">humans</span>
SIVsmm is a simian immunodeficiency virus that persists efficiently without causing disease in naturally infected sooty mangabeys (SMs) but induces AIDS upon cross-species transmission to humans and macaques. Current phylogenetic data indicate that SIVsmm strains comprise a highly diverse group of viruses that can be subdivided into different lineages. Since only certain SIVsmm strains have successfully crossed the species barrier to humans and macaques, the question has been raised whether there are lineage specific differences in SIVsmm biology. In the present study we examined whether representatives of five different SIVsmm lineages show differences in the function of the accessory Nef protein, which plays an important role in viral persistence, transmission and pathogenesis.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 178 183 <span type="species:ncbi:9606">human</span>
###xml 359 364 <span type="species:ncbi:9606">human</span>
We found that nef alleles from all SIVsmm lineages down-modulated CD4, MHC-I, CD28 and CD3 and up-regulated the invariant chain (Ii) associated with immature MHC-II molecules in human-derived cells. Moreover, they generally suppressed the responsiveness of virally infected T cells to activation, enhanced virion infectivity and promoted virus replication in human peripheral blood mononuclear cells. The functional activity of these nef alleles in the various assays varied substantially between different strains of SIVsmm but quantitative analyses did not reveal any significant lineage-specific differences in Nef function.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nef </italic>
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 250 253 <span type="species:ncbi:9531">SMs</span>
###xml 311 316 <span type="species:ncbi:9606">human</span>
Nef alleles from different lineages of SIVsmm do not require adaptive changes to be functionally active in human cells. Strain rather than lineage-specific differences in Nef function may impact the virological and immunological feature of SIVsmm in SMs and possibly affected viral fitness and pathogenicity in human and macaque hosts.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 148 175 148 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pan troglodytes troglodytes</italic>
###xml 216 231 216 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cercocebus atys</italic>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 739 740 739 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 856 857 856 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 135 146 <span type="species:ncbi:9598">chimpanzees</span>
###xml 148 175 <span type="species:ncbi:37011">Pan troglodytes troglodytes</span>
###xml 193 208 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 210 213 <span type="species:ncbi:9531">SMs</span>
###xml 216 231 <span type="species:ncbi:9531">Cercocebus atys</span>
###xml 258 264 <span type="species:ncbi:9606">humans</span>
###xml 283 288 <span type="species:ncbi:9606">human</span>
###xml 315 318 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 447 452 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 516 522 <span type="species:ncbi:9606">humans</span>
###xml 569 574 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 603 608 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 650 655 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 721 726 <span type="species:ncbi:9606">human</span>
To date primate lentiviruses have been detected in about 40 African non-human primate species [1,2]. Two of these viruses, SIVcpz from chimpanzees (Pan troglodytes troglodytes) and SIVsmm from sooty mangabeys (SMs) (Cercocebus atys) have been transmitted to humans and generated the human immunodeficiency viruses (HIV) types 1 and 2, respectively [3,4]. SIVcpz strains are known to have crossed the species barrier on three occasions, generating HIV-1 groups M, N and O. In contrast, SIVsmm has been transmitted to humans no fewer than eight times [5,6]. Nonetheless, HIV-2 is much less prevalent than HIV-1, with only two transmissions (leading to HIV-2 groups A and B) resulting in significant secondary spread in the human population [7-9]. The remaining transmissions appear to have caused dead-end infections affecting only a handful of individuals [9-11]. SIVsmm was also inadvertently transmitted to captive macaques, generating SIVmac. Currently, experimental infection of macaques with SIVmac is commonly used as a model for studies of AIDS pathogenesis and vaccines [12].
###end p 9
###begin p 10
###xml 55 56 55 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 987 989 987 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1069 1071 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 308 313 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 459 474 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 650 655 <span type="species:ncbi:9606">human</span>
###xml 1064 1067 <span type="species:ncbi:9531">SMs</span>
###xml 1198 1203 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1211 1216 <span type="species:ncbi:9606">human</span>
SIVsmm exhibits a prevalence of about 60% in the wild [6] and comprises a genetically highly diverse group of viruses [13]. Previous studies suggest that different SIVsmm strains may differ in their fitness and pathogenic features after cross-species transmission. As mentioned above, only groups A and B of HIV-2 resulted in epidemics. Furthermore, SIVmac strains differ substantially in their ability to persist efficiently and to cause disease in infected rhesus macaques [14,15]. It has been shown that serial passage of SIVsmm in macaques increases viral pathogenicity in this experimental host [16,17]. Thus, differences in viral adaptation to human or macaque hosts may play a role in the ability of this virus to persist and cause disease after cross-species transmission [18-20]. However, intrinsic differences in viral properties may also exist. For example, it has recently been suggested that different SIVsmm lineages vary in their ability to cause a significant loss of CD4+ T cells [21] that is observed in about 10 to 15% of the naturally infected SMs [22]. Lineage-specific differences in viral fitness may also have contributed to the differential spread of the various groups of HIV-2 in the human population.
###end p 10
###begin p 11
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 883 885 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1012 1014 1012 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1015 1017 1015 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1119 1121 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1241 1243 1241 1243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1281 1283 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 409 412 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 417 422 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 651 654 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 659 662 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 816 821 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 831 837 <span type="species:ncbi:9606">humans</span>
###xml 866 881 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 893 898 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1096 1099 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1276 1279 <span type="species:ncbi:9531">SMs</span>
One viral factor that plays an important role in the efficiency of primate lentiviral persistence and transmission is the Nef protein. Nef performs multiple activities, such as modulation of cell surface expression of CD4, CD28, class I MHC (MHC-II) and the invariant chain (Ii) associated with immature MHC-II molecules, as well as enhancement of viral infectivity and replication [23-29]. In addition, most SIV and HIV-2 Nefs also down-modulate CD3, a key component of the T cell receptor (TCR) complex from the cell surface [30]. It is well established that differences in Nef function affect the virological, immunological and clinical outcome of HIV and SIV infection [31]. Perhaps most importantly, the lack of a functional nef gene is associated with very low viral loads and an attenuated clinical course in HIV-1-infected humans [32-34] and SIVmac-infected rhesus macaques [35]. Some HIV-1 and SIVmac strains that contain naturally occurring point mutations or small deletions in Nef are less virulent [36-39], while other alterations in Nef are associated with acutely fatal disease in SIV-infected macaques [40,41]. Recently, it has been shown that inefficient Nef-mediated down-modulation of CD3 and MHC-I correlates with low CD4+ T cell counts in SIVsmm-infected SMs [42].
###end p 11
###begin p 12
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 413 417 413 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 479 484 <span type="species:ncbi:9606">human</span>
It has been shown that primary SIVsmm nef alleles are functionally active in human-derived cells [42,43]. It is currently unknown, however, whether SIVsmm shows lineage-specific differences in Nef function that may affect virus replication or pathogenicity. To address this question we performed a comprehensive functional analysis of nef alleles derived from five different lineages of SIVsmm. We found that all nef alleles were capable of modulating cell surface expression of human CD4, CD28, CD3, MHC-I and Ii molecules. Furthermore, they enhanced virion infectivity, promoted viral replication and suppressed the responsiveness of virally infected T cells to activation. Although the magnitude of these various Nef functions varied, we did not find significant lineage-specific differences.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Animals
###end title 14
###begin p 15
###xml 535 537 535 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 59 62 <span type="species:ncbi:9531">SMs</span>
###xml 510 513 <span type="species:ncbi:9531">SMs</span>
###xml 581 584 <span type="species:ncbi:9531">SMs</span>
Blood samples were collected from seven naturally infected SMs housed at the Tulane National Primate Research Center (TNPRC), which represented five different SIVsmm lineages (Ls) based on previous analyses: L1 (M919, M923), L2 (M926, M946), L3 (M949, M951) and L4 (G932) (summarized in Table 1). One L5 SIVsmm strain was isolated on SM PBMC from an animal (FTq) housed at the Yerkes National Primate Research Center (YNPRC) of Emory University. We also included data derived from 22 naturally SIVsmm-infected SMs with differential CD4+ T cell counts housed at the YNPRC [42]. All SMs were maintained in accordance with NIH guidelines. The identification and characterization of the different lineages of SIVsmm has been described [13,21].
###end p 15
###begin title 16
Nef alleles and proviral constructs
###end title 16
###begin p 17
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 624 628 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 727 731 727 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 856 860 856 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 866 869 866 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 921 925 921 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 88 91 <span type="species:ncbi:9531">SMs</span>
###xml 254 259 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 752 757 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 967 970 <span type="species:ncbi:9531">SMs</span>
SIVsmm nef alleles were amplified by RT-PCR from the plasma of seven naturally infected SMs or the supernatant of an SIVsmm FTq infected SM PBMC culture as described previously [42]. Splice-overlap-extension PCR was used to replace the NL4-3 nef gene of HIV-1 (NL4-3 based) proviral constructs carrying functional nef genes followed by an internal ribosome entry site (IRES) [30] with the bulks of SIVsmm nef genes [42]. Cloning and transformation efficiencies were determined and the integrity of all PCR-derived inserts was confirmed by sequence analysis as reported previously [42]. For comparison, we also sequenced the nef coding region of three individual clones from each of the proviral plasmids expressing bulk SIVsmm nef alleles. The control HIV-1 NL4-3-IRES-eGFP constructs expressing the NL4-3, NA7 and SIVmac239 Nefs or containing a disrupted nef gene (nef-) and the amplification and functional analysis of nef alleles from 22 naturally SIVsmm-infected SMs housed at the YNPRC have been reported previously [42].
###end p 17
###begin title 18
Cell culture and virus stocks
###end title 18
###begin p 19
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 717 719 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 178 184 <span type="species:ncbi:9913">bovine</span>
###xml 210 215 <span type="species:ncbi:9606">human</span>
###xml 517 522 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Jurkat and 293T cells were cultured as described previously [30]. Briefly, 293T cells were maintained in Dulbecco's modified Eagle's medium containing 10% heat-inactivated fetal bovine serum. PBMC from healthy human donors were isolated using lymphocyte separation medium (Biocoll Separating Solution, Biochrom), stimulated for 3 days with PHA (1 mug/ml) and cultured in RPMI1640 medium with 10% FCS and 10 ng/ml IL-2 prior to infection. To generate viral stocks, 293T cells were transfected either with the proviral HIV-1 constructs alone (to measure viral infectivity or replication) or cotransfected with a plasmid (pHIT-G) expressing the Vesicular Stomatitis Virus G protein (VSG-G) for flow cytometric analyses [44]. The medium was changed after overnight incubation and the virus was harvested 24 h later. Residual cells in the supernatants were pelleted and the supernatants were stored at -70degreesC. Virus stocks were quantified using a p24 antigen capture assay provided by the NIH AIDS Research and Reference Reagent Program.
###end p 19
###begin title 20
Transduction and flow cytometry
###end title 20
###begin p 21
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 512 515 512 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Jurkat T cells or PBMC were transduced with HIV-1 (NL4-3) constructs coexpressing eGFP and various nef alleles and CD4, TCR-CD3, MHC-I, CD28, CD25, CD69 and eGFP expression was measured as described [30,42]. For quantification of Nef-mediated modulation of specific surface molecules, the levels of receptor expression (red fluorescence) were determined for cells expressing a specific range of eGFP. The extent of down-modulation (n-fold) was calculated by dividing the MFI obtained for cells infected with the nef-minus NL4-3 control viruses by the corresponding values obtained for cells infected with viruses coexpressing Nef and eGFP.
###end p 21
###begin title 22
NFAT assay
###end title 22
###begin p 23
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 472 474 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 128 133 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Jurkat cells stably transfected with an NFAT-dependent reporter gene vector [45] were either left uninfected or transduced with HIV-1 Nef/eGFP constructs expressing various nef alleles. Except for those cells used as controls, cultures were treated with PHA (1 mug/ml; Murex). Luciferase activity was measured and n-fold induction determined by calculating the ratio between measured relative light units of treated samples over untreated samples as described previously [30].
###end p 23
###begin title 24
Viral infectivity
###end title 24
###begin p 25
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
Virus infectivity was determined using P4-CCR5, TZM-bl and CEM-M7 cells as described [46]. Briefly, the cells were sown out in 96-well-dishes in a volume of 100 mu1 and infected after overnight incubation with virus stocks containing 1 ng of p24 antigen produced by transiently transfected 293T cells. Two days post-infection viral infectivity was detected using the Gal screen kit from TROPIX as recommended by the manufacturer. beta-galactosidase activities were quantified as relative light units per second (RLU/s) using the Orion Microplate Luminometer.
###end p 25
###begin title 26
Virus spread in PBMCs
###end title 26
###begin p 27
###xml 60 62 60 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 316 318 316 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
To assess the ability of Nef to promote viral spread, 2 x 105 pre-stimulated PBMC per well were sown out in 48-well dishes and infected with 293T cell derived virus stocks containing one 1 ng of p24 antigen. Aliquots of the cells were obtained at 3, 5 and 7 days post-infection and the number of virally infected GFP+ cells was determined by flow cytometric analysis.
###end p 27
###begin title 28
Phylogenetic analysis
###end title 28
###begin p 29
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
The nef sequences derived from the different lineages of SIVsmm analyzed in the present were compared to published SIVsmm nef sequences (accession numbers ,  to  and  to ). They were aligned using ClustalW [47]. The tree in Fig. 1 was inferred by the Bayesian method [48] in MrBayes [49] using 10 million generations and the HKY model [50] with gamma distributed rates at sites [51] and burn in of 25%. Average standard deviation of split frequencies (< 0.003) was checked to see that a sufficient number of generations had been run.
###end p 29
###begin p 30
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Evolutionary relationships among HIV-2 and SIVsmm Nef sequences</bold>
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 33 38 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Evolutionary relationships among HIV-2 and SIVsmm Nef sequences. SIVsmm nef alleles newly analyzed in the present study and the SIVmac239 nef are highlighted by yellow and orange boxes, respectively. The tree in was inferred by the Bayesian method [48] MrBayes [49] using 10 million generations and the HKY model [50] with gamma distributed rates at sites [51] and burn in of 25%. Numbers on branches are percentage estimated posterior probabilities. Only those 95% and above are shown.
###end p 30
###begin title 31
Statistical methods
###end title 31
###begin p 32
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
The activities of nef alleles were compared using a two-tailed Student's t test. The PRISM package version 4.0 (Abacus Concepts, Berkeley, CA) was used for all calculations.
###end p 32
###begin title 33
GenBank accession numbers
###end title 33
###begin p 34
The GenBank accession numbers for the SIVsmm nef sequences are FJ943640 to FJ943647.
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
Generation of viral constructs coexpressing Nefs from different SIVsmm lineages and eGFP
###end title 36
###begin p 37
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag</italic>
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol </italic>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 606 610 606 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 630 634 630 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 729 734 729 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HpaI </italic>
###xml 738 743 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MluI </italic>
###xml 870 874 870 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 971 975 971 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nef </italic>
###xml 1408 1412 1408 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1730 1734 1730 1734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 447 452 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 600 605 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Extensive studies of SIVsmm diversity identified no less than nine different phylogenetic lineages of this virus in the animal cohorts housed at the Yerkes and Tulane National Primate Research Centers [13,21]. To assess whether SIVsmm shows lineage-specific differences in Nef function, we cloned nef alleles from 8 animals known to belong to five different clades based on the analysis of their gag, pol and env sequences [13,21] in bulk into an HIV-1 NL4-3-based IRES-eGFP proviral vector co-expressing Nef and eGFP from a bi-cistronic RNA. To generate these proviral constructs, the 3' end of the HIV-1 env gene and the SIVsmm nef alleles were fused by splice-overlap-extension (SOE) PCR using outer primers containing unique HpaI and MluI restriction sites and overlapping inner primers and cloned in bulk into the proviral constructs. As summarized in Table 1, the nef alleles represented SIVsmm lineages 1 (M919, M923), 2 (M926, M946), 3 (M949, M951) and 4 (G932). Nef genes from an L5 SIVsmm strain (FTq) were amplified from the supernatant of an infected SM PBMC culture. We found that sequences obtained by direct analysis of the PCR products and bulk inserts in the NL4-3-based IRES-eGFP vector were indistinguishable (data not shown). As further control, we sequenced three individuals' proviral clones for each of the eight animal samples. We found that all 24 proviral constructs encoded intact nef open reading frames and that these sequences were closely related to those obtained by direct sequencing of the corresponding PCR fragments and formed animal-specific clades for each of the eight SIVsmm strains. These results verified the accuracy of the proviral constructs and showed that the frequency of defective nef alleles is low.
###end p 37
###begin title 38
SIVsmm nef sequence and phylogenetic analysis
###end title 38
###begin p 39
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 299 303 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 499 500 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1058 1059 1058 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1141 1143 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1144 1146 1144 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1275 1277 1275 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1400 1402 1400 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 1403 1405 1403 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1510 1512 1510 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 1606 1610 1606 1610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 705 710 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1263 1268 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Phylogenetic analyses showed that the proviral NL4-3 IRES/eGFP plasmid preparations contained highly divergent nef alleles that belonged to distinct clusters (Fig. 1). Importantly, this analysis demonstrated that all sequences were animal specific, thus confirming the authenticity of the amplified nef genes and excluding cross-sample PCR contaminations. Closer examination of the amplified sequences showed that all nef genes predicted full-length proteins of 265 or 267 amino acid residues (Fig. 2). The N- and C-termini of the SIVsmm Nef amino acid sequences were highly variable, whereas the central core region was well conserved. Some domains and protein interaction sites known to be relevant for HIV-1 function [52], such as the N-terminal myristoylation signal, an N-proximal basic region involved in membrane targeting, an acidic region, a di-arginine motif, a "di-leucine-based" (EXXXLM/V) adaptor-protein interaction site in the C-proximal flexible loop and a di-acidic putative V1H binding site were preserved in all SIVsmm Nef sequences (Fig. 2). In contrast, N-proximal Y residues, proposed to represent endocytosis signals [53,54], and the "proline-rich" region, which is highly conserved and involved in the interaction with cellular kinases in HIV-1 Nefs [55], differed in several SIVsmm Nef sequences. In contrast, Y223, which is critical for MHC-I down-modulation by SIVmac Nef [56,57] and residues P73A74 and D204, critical for CD4 down-modulation and efficient replication of SIVmac239 [58], were generally conserved at the corresponding position. Altogether, the examination of the nef sequences from the different clades of SIVsmm did not reveal any peculiar abnormalities.
###end p 39
###begin p 40
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alignment of SIV and HIV-2 Nef sequences</bold>
###xml 13 16 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 21 26 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Alignment of SIV and HIV-2 Nef sequences. The SIVmac239 sequence is shown in the upper panel for comparison. Some conserved sequence elements in Nef, including the N-terminal myristoylation signal, N-proximal tyrosines (52-54), PA residues known to be critical for CD4 down-modulation by 239 wt Nef (58), the acidic and proline-rich regions, a diarginine motif, a C-proximal adaptor-protein (AP) interaction site (52), a diacidic putative VlH binding site and a Y residue involved in MHC-I down-regulation (52, 56,57) are indicated schematically. Dots indicate identity with the 239 wt Nef sequence and dashes gaps introduced to optimize the alignment.
###end p 40
###begin title 41
###xml 53 58 <span type="species:ncbi:9606">human</span>
Nef alleles from different clades of SIVsmm modulate human receptors
###end title 41
###begin p 42
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 789 793 787 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 988 992 986 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1102 1103 1100 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1150 1152 1148 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1205 1207 1203 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 1344 1346 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 1514 1516 1512 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 2079 2081 2077 2079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 2126 2130 2124 2128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 2249 2251 2247 2249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 2304 2306 2302 2304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 2598 2600 2596 2598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 2609 2613 2607 2611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 2936 2940 2934 2938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 153 158 <span type="species:ncbi:9606">human</span>
###xml 556 559 <span type="species:ncbi:9531">SMs</span>
###xml 943 948 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2180 2183 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 2209 2214 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2663 2668 <span type="species:ncbi:9606">human</span>
To compare the potency of nef alleles from different SIVsmm lineages in down-modulating CD3, CD4, CD28 and MHC-I, and in up-regulating Ii, we transduced human PBMC with the proviral constructs and analyzed them by flow cytometry (Fig. 3A). As reported previously [30], the proviral NL4-3 Nef/eGFP constructs have the advantage that infected cells co-express Nef and eGFP from single bicistronic RNAs, thus allowing to correlate Nef and receptor expression levels (Fig. 3A). To ensure that the nef alleles were representative for each of the eight infected SMs investigated, they were cloned in bulk into the proviral vector and viral stocks were derived from >/=50 independent transformants (data not shown). For comparison, we also analyzed clones expressing an individual primary SIVsmm nef allele from each animal. The results confirmed the data obtained from the analyses of Nef function in bulk (data not shown). As expected, the control HIV-1 NL4-3 construct containing a disrupted nef gene only affected CD4, since Vpu and Env also reduce its expression at the surface of infected T cells (Fig. 3, column 2). In agreement with published data [30], the NL4-3 Nef did not down-modulate TCR-CD3 (Fig. 3A, column 3). In contrast, the 239 wt and the eight SIVsmm Nefs modulated the surface expression of all four receptors investigated (Fig. 3A, columns 4-12). Quantitative analyses demonstrated that Nefs from all five lineages of SIVsmm showed similar potency in down-modulating CD3, CD4, MHC-I and CD28 (Fig. 3B). Notably, the 239 wt Nef was more active than all SIVsmm Nefs in receptor modulation. This difference was particularly striking in Nef functions involved in T cell receptor (TCR) signalling. SIVsmm Nefs generally reduced CD3 cell surface expression about 3-fold, whereas the 239 wt Nef caused 6-fold down-modulation. The functional difference in down-modulation of the co-stimulatory factor CD28 was even more pronounced: all SIVsmm Nef alleles caused only about 2-fold lower levels of CD28 surface expression, whereas the 239 wt Nef reduced it by 6-fold (Fig. 3B). We also examined the effect of the SIVsmm nef alleles on CXCR4, which is down-modulated by many SIV and (to a lesser extend) HIV-1 Nefs to inhibit T cell migration [59]. This analysis was performed in Jurkat cells (Fig. 4A) instead of PBMCs because the latter express very low levels of CXCR4 upon PHA stimulation precluding the meaningful analysis of the Nef function (data not shown). We found that the 239 wt Nef down-modulated CXCR4 by 7.6-fold, whereas all SIVsmm Nefs had only 3.0- to 4.5-fold effects (Fig. 4B). Thus, nef alleles from all five lineages of SIVsmm modulate human receptors involved in TCR signalling and T cell migration, albeit generally with lower efficiency than the 239 wt Nef. Unfortunately, no SIVsmm-specific Nef antibodies are available. Thus, the Nef expression levels could not be determined, although the fact that all nef alleles were functionally active implies that they are efficiently expressed.
###end p 42
###begin p 43
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Modulation of receptor expressed by human PBMC by SIVsmm <italic>nef </italic>alleles</bold>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 752 756 750 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 863 867 861 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 910 915 908 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nefs </italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 114 119 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 748 751 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 820 825 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 857 862 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Modulation of receptor expressed by human PBMC by SIVsmm nef alleles. (A) PBMCs (panels A-D) were transduced with HIV-1 NL4-3 constructs coexpressing the indicated nef alleles and GFP and assayed for surface expression of CD4, CD3, CD28 and MHC-I. The ranges of eGFP expression used to calculate receptor modulation are indicated. (B) Quantitative assessment of SIVsmm Nef-mediated down-modulation of the indicated cellular receptors. The animal specifications and SIVsmm lineages are indicated and the activities obtained using the SIVmac Nef are shown for comparison. Values give averages +/- SD derived from three independent experiments. The asterisks denote a statistical significance (P < 0.05) between SIVmac239 and SIVsmm Nef activity. All SIV nef alleles were significantly (P < 0.001) more active than that of HIV-1 in modulating CD3, whereas the HIV-1 nef was more active (P < 0.05) than all SIVsmm nefs in down-regulation of MHC-I.
###end p 43
###begin p 44
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Modulation of CXCR4 and the MHC-II associated invariant chain</bold>
###xml 432 436 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 103 108 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 382 387 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 789 794 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 799 802 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Modulation of CXCR4 and the MHC-II associated invariant chain. (A) Jurkat T cells were transduced with HIV-1 NL4-3 Nef/eGFP constructs and assayed for surface expression of CXCR4. The range of eGFP expression used to calculate CXCR4 modulation is indicated. (B) Quantitative assessment of down-modulation of CXCR4 by the indicated Nef proteins. (C) THP-1 cells were transduced with HIV-1 NL4-3 constructs coexpressing the indicated nef alleles and GFP and assayed for surface expression of Ii. The ranges of eGFP expression used to calculate receptor modulation are indicated. (D) Quantitative assessment of SIVsmm Nef-mediated down-modulation of Ii. Values give averages +/- SD derived from five independent experiments. The asterisks denote a statistical significance (P < 0.05) between HIV-1 and SIV Nef activity.
###end p 44
###begin p 45
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 462 466 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 738 742 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 34 37 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 42 45 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 290 295 <span type="species:ncbi:9606">human</span>
###xml 425 430 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 806 811 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 863 866 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 976 981 <span type="species:ncbi:9606">human</span>
###xml 1234 1249 <span type="species:ncbi:9544">rhesus macaques</span>
It has been previously shown that HIV and SIV Nefs up-regulate Ii, most likely to impair MHC-II antigen presentation [29,60]. We transduced the human monocytic leukemia THP-1 cell line with the NL4-3 Nef-IRES/eGFP constructs to study Ii up-modulation because it shares many properties with human monocyte-derived macrophages [61] and expresses high levels of MHC-I and MHC-II. As expected [60], THP-1 cells infected with the HIV-1 construct expressing the NL4-3 nef allele showed strongly enhanced levels of Ii surface expression (Fig. 4C). The SIVsmm Nefs varied substantially in their ability to up-modulate Ii. Those from M949 (L3) and G932 (L4) up-regulated Ii cell surface expression about 4-fold, whereas the M919 (L1) and FTq (L5) nef alleles caused less than 2-fold effects (Fig. 4D). Notably, the HIV-1 NL4-3 Nef was about 2-fold more effective than all SIV Nefs in up-modulating Ii. Taken together, these data demonstrate that the ability of Nef to modulate various human receptors involved in TCR signalling and MHC antigen presentation is conserved between the different lineages of SIVsmm. Our results also strongly suggest that the SIVmac239 Nef became more effective in some of these functions during its adaptation to rhesus macaques.
###end p 45
###begin title 46
SIVsmm Nefs suppress T cell activation
###end title 46
###begin p 47
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 1275 1277 1275 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 608 613 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 682 687 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1012 1017 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We next examined the effect of the various SIVsmm nef alleles on the responsiveness of virally infected T cells to activation. It has been previously shown that Nefs that down-modulate TCR-CD3 to suppress the responsiveness of infected T cells to stimulation, whereas those that do not perform this function have little inhibitory effect or even render the cells hyper-responsive to stimulation [30,43,45,62,63]. In agreement with these previous results, the about 5-fold increase in the expression levels of the early T cell activation marker CD69 upon PHA stimulation was blocked in PBMC infected with the HIV-1 construct expressing the 239 wt Nef but not in those expressing the HIV-1 NL4-3 or NA7 Nef proteins (Fig. 5A, panels 2-4). Consistent with their lower activity in CD3 down-modulation, the SIVsmm Nefs suppressed the induction of CD69 expression less efficiently than the 239 wt Nef (Fig. 5B, left). Nonetheless, they interfered with early T cell activation substantially more severely than those of HIV-1. In comparison, the SIVsmm Nefs had only weak inhibitory effects on the induction of CD25 at 2 days post-stimulation, whereas PBMC expressing the 239 wt Nef showed markedly (about 2.5-fold) reduced surface levels of this late T cell activation marker (Fig. 5B, right).
###end p 47
###begin p 48
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Modulation of T activation by SIVsmm <italic>nef </italic>alleles</bold>
###xml 50 54 50 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 506 510 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 586 590 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 121 126 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 196 201 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 453 458 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 761 766 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 771 774 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Modulation of T activation by SIVsmm nef alleles. (A) PBMCs were transduced with replication-competent VSV G pseudotyped HIV-1 particles expressing either GFP alone (panel 1) or together with the HIV-1 NL4-3 and NA7 (panels 2 and 3), 239 wt (panel 4) or SIVsmm nef alleles (panels 5 to 12) and stained for CD69 and CD25 expression. Similar results were obtained in two independent experiments. (B) CD69 and CD25 expression levels on PBMCs infected with HIV-1 constructs coexpressing eGFP and the indicated nef alleles are shown relative to those measured on T cells transduced with the nef defective control virus (100%). Values give averages +/- SD derived from three independent experiments. The asterisks denote a statistical significance (P < 0.05) between HIV-1 and SIV Nef activity.
###end p 48
###begin p 49
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 688 692 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 830 831 830 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1186 1187 1186 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1258 1262 1258 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1363 1367 1363 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 591 596 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 702 707 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 933 938 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1252 1257 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activation of the nuclear factor of activated T cells (NFAT) plays a key role in T cell activation and regulates the transcription of many cellular genes, including that encoding for IL-2. It has been established that primate lentiviral Nef proteins differ fundamentally in their effect on the induction of NFAT [30,45]. To assess the effect of nef alleles from different lineages of SlVsmm on NFAT activation in virally infected cells, we transduced Jurkat T cells stably transfected with the luciferase reporter gene under the control of an NFAT-dependent promoter [45], with the proviral HIV-1 eGFP/Nef constructs and examined their responsiveness to activation. T cells infected with nef defective HIV-1 construct showed about 5-fold enhanced levels of NFAT activity upon PHA stimulation compared to mock infected cells (Fig. 6). As expected from previous studies [30,45], this increase was further enhanced by expression of the HIV-1 NL4-3 and NA7 Nefs but entirely blocked by the 239 wt Nef. Despite their reduced potency in CD3 and CD28 down-modulation, all SIVsmm Nefs suppressed the induction of NFAT-dependent luciferase activity almost as efficiently as the 239 wt Nef (Fig. 6). Compared to T cells infected with viral constructs containing HIV-1 nef alleles they expressed about 5- to 10-fold lower levels of NFAT-dependent luciferase activity. Thus, nef alleles from all five lineages of SIVsmm suppress the responsiveness of infected T cells to stimulation, albeit with lower potency than that of SIVmac239.
###end p 49
###begin p 50
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SIVsmm <italic>nef </italic>alleles inhibit NFAT induction</bold>
###xml 166 171 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 397 402 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 407 410 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
SIVsmm nef alleles inhibit NFAT induction. Analysis of Jurkat cells stably transfected with an NFAT-dependent reporter gene following transduction with the indicated HIV-1 Nef/eGFP constructs and subsequent stimulation with PHA. Levels of NFAT-dependent luciferase reporter activity are the average (+/- SD) of triple infections. The asterisks denote a statistical significance (P < 0.01) between HIV-1 and SIV Nef activity. Similar results were obtained in two independent experiments.
###end p 50
###begin title 51
SIVsmm Nefs enhance viral infectivity and replication
###end title 51
###begin p 52
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 711 715 711 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 888 889 888 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 935 936 935 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 941 942 941 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1023 1024 1023 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1187 1189 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 1415 1419 1415 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1562 1564 1562 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 1666 1670 1666 1670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1768 1770 1768 1770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 1953 1955 1953 1955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 1956 1958 1956 1958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 1967 1971 1967 1971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1451 1456 <span type="species:ncbi:9606">human</span>
###xml 1751 1756 <span type="species:ncbi:9606">human</span>
###xml 1845 1850 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2067 2072 <span type="species:ncbi:9606">human</span>
The proviral HIV-1 IRES/eGFP constructs are replication-competent and hence allow to measure the ability of Nef to promote viral infectivity and replication. To assess the ability of the SIVsmm Nefs to enhance virion infectivity we infected P4-CCR5 [64], TZM-bl [65,66] and CEMx174 5.25 M7 (CEMx-M7) indicator cells with virus stocks containing 1 ng of p24 antigen derived from 293T cells transiently transfected with the different proviral constructs. We found that the control NL4-3 and 239 wt Nef proteins enhanced virion infectivity 4.0- and 5.6-fold, respectively, in P4-CCR5 cells (Fig. 7A) but had little if any enhancing effects in TZM-bl and CEM-M7 cells (Fig. 7B and data not shown). All eight SIVsmm nef alleles analyzed also enhanced viral infectivity in P4-CCR5 cells (Fig. 7A). However, although they showed similar potency in down-modulating CD3, CD4, CD28 and MHC-I (Fig. 3) and in suppressing T cell activation (Figs. 5 and 6) they varied substantially in their ability to promote virion infectivity (Fig. 7). The L1 and L2 M919, M923, M926 and M946 Nefs were more effective than the NL4-3 and 239 wt Nefs and increased virus infection between 10.0- and 17.4-fold (Fig. 7A). In comparison, the L4 G932 Nef was poorly active in enhancing virion infectivity (2.4-fold enhancement) and the remaining L3 and L5 Nefs showed an intermediate phenotype. Next, we investigated whether the eight SIVsmm bulk nef alleles promote viral spread in human PBMC cultures. We found that all SIVsmm Nefs enhanced viral replication with 239wt-like efficiency (Fig. 8A). In contrast to their differential effects on virion infectivity in P4-CCR5 cells, the eight SIVsmm nef alleles did not differ significantly in their ability to promote viral spread in human PBMC (Fig. 8B). This is consistent with previous results showing that the efficiency of HIV-1 replication does not correlate with the ability of Nef to enhance the infectivity of progeny virions [67,68]. Thus, nef alleles from all five lineages of SIVsmm are capable to promote viral spread and infectivity in human cells without adaptive changes.
###end p 52
###begin p 53
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SIVsmm <italic>nef </italic>alleles enhance viral infectivity</bold>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 61 66 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 180 185 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 238 241 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
SIVsmm nef alleles enhance viral infectivity. Infectivity of HIV-1 NL4-3 variants containing the indicated nef alleles. (A) P4-CCR5 or (B) TZM-bl reporter cells were infected with HIV-1 NL4-3 IRES-eGFP constructs containing the indicated HIV and SIVsmm nef genes or a disrupted nef allele. Infections were performed in triplicate with two different virus stocks containing 1 ng p24 antigen. RLU/s, relative light units per second. All nef alleles (except G932) significantly (P < 0.05) enhanced virion infectivity in P4-CCR5 but not in CEM-M7 cells.
###end p 53
###begin p 54
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Enhancement of viral replication by SIVsmm <italic>nef </italic>alleles</bold>
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 277 279 277 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 432 434 432 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 574 578 572 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 671 674 669 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 414 419 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 634 639 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Enhancement of viral replication by SIVsmm nef alleles. (A) Replication kinetics of recombinant NL4-3 variants containing the indicated nef alleles in PBMCs are shown. Infections were performed using virus stocks containing 1 ng p24 antigen. The numbers of virally infected GFP+ cells was measured by flow cytometric analysis. Similar results were obtained in two independent experiments (B) Cumulative numbers of HIV-1-infected GFP+ cells detected in PBMC cultures at days 3, 5 and 7 post-infection. Shown are averages +/- SD derived from three independent infections. All nef alleles significantly (P < 0.05) enhanced the number of HIV-1-infected cells compared to the nef-defective control virus.
###end p 54
###begin title 55
Subgroup-specific analysis of previously investigated SIVsmm Nefs
###end title 55
###begin p 56
###xml 375 379 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 480 482 478 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 497 499 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 603 605 601 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 798 802 796 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 898 899 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 918 922 916 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1001 1005 999 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1110 1111 1108 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1120 1124 1118 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1183 1187 1181 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1455 1460 1453 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A, B</xref>
###xml 1477 1481 1475 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1603 1605 1601 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 1719 1721 1717 1719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9D</xref>
###xml 1768 1769 1766 1767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 1776 1780 1774 1778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1869 1871 1867 1869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9E</xref>
###xml 1898 1900 1896 1898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1976 1978 1974 1976 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2069 2071 2067 2069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9F</xref>
###xml 2211 2213 2209 2211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9F</xref>
###xml 2266 2270 2264 2268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 2316 2318 2314 2316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 178 183 <span type="species:ncbi:9606">human</span>
###xml 414 417 <span type="species:ncbi:9531">SMs</span>
###xml 650 653 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 2057 2062 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2283 2286 <span type="species:ncbi:9531">SMs</span>
The data described above show that Nefs from different lineages of SIVsmm are basically capable to modulate various receptors and to enhance viral infectivity and replication in human-derived cells. As a first step to elucidate whether different lineages of SIVsmm show quantitative differences in Nef function, we re-analyzed data derived from the functional analysis of 22 nef alleles from 14 naturally infected SMs with low (<500/mul) and eight animals with high (>500/mu1) CD4+ T cell counts [42]. This study showed that inefficient down-modulation of CD3 and MHC-I by Nef is associated with low CD4+ T cell counts in this natural simian host of SIV but did not assess whether these SIVsmm Nefs show lineage-specific differences in Nef function. Phylogenetic analyses showed that two of the 22 nef sequences clustered with the L5 FTq sequence and four with the L3 M951 and M949 sequences (Fig. 1). These L3 and L5 nef sequences formed two distinct clusters. In comparison, the remaining 16 SIVsmm nef sequences were more closely related to those derived from the more common SIVsmm L1 and L2 strains (Fig. 1). These nef sequences showed a high degree of genetic diversity and L2 nef alleles fell within the L1 cluster. Therefore, we grouped them together and refer to them herein after as L1/2 Nefs. Examination of the functional data showed that, on average, L1/2, L3 and L5 SIVsmm Nefs showed similar activities in down-modulating CD4 and CD3 (Fig. 9A, B). All 22 SIVsmm nef alleles had only weak effects on CD28, although those derived from L3 were usually a little more active than others (Fig. 9C). These lineages of SIVsmm did also not show a significant differences in Nef-mediated modulation of MHC-I (Fig. 9D). In agreement with the results shown in Fig. 8, L1/2 nef alleles were, on average, more potent in enhancing virion infectivity than L3 Nefs (Fig. 9E). As reported previously [42], Nef alleles from a single SIVsmm-infected SM with very low numbers of CD4+ T cells rendered T cells hyper-responsive to activation, similarly to those of HIV-1 (Fig. 9F). The remaining SIVsmm Nefs all suppressed NFAT induction and did not show significant lineage-specific differences in this activity (Fig. 9F). Altogether, these results demonstrate that SIVsmm nef alleles from SMs with different numbers of CD4+ helper T cells show substantially functional differences but these are strain rather than lineage dependent.
###end p 56
###begin p 57
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 56 58 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 0 140 0 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SIVsmm <italic>nef </italic>alleles derived from SMs with high or low CD4<sup>+ </sup>T cell counts do not show significant lineage-specific differences in Nef function</bold>
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 619 623 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 740 744 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 765 769 765 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1143 1147 1143 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1196 1200 1196 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 32 35 <span type="species:ncbi:9531">SMs</span>
###xml 675 680 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1117 1122 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1176 1179 <span type="species:ncbi:9531">SMs</span>
SIVsmm nef alleles derived from SMs with high or low CD4+ T cell counts do not show significant lineage-specific differences in Nef function. (A-D) Modulation of cellular receptors by primary nef alleles derived from different lineages of SIVsmm. Each symbol represents n-fold down-modulation of the indicated receptor molecule by one of the 22 NL4-3 recombinants expressing primary bulk SIVsmm nef alleles analyzed. Similar results were obtained in two independent experiments. L1 and L2 nef alleles were combined since they did not form two distinct clusters (Fig. 1). (E) Enhancement of virion infectivity by SIVsmm nef alleles. P4-CCR5 indicator cells were infected with HIV-1 NL4-3 IRES-eGFP constructs containing the indicated SIVsmm nef genes or a defective nef allele. Infections were performed in triplicate with two different virus stocks containing 1 ng p24 antigen. Each symbol represents the average value of the 6 measurements compared to the infectivity of the virus expressing the SIVmac239 Nef (100%). (F) Levels of NFAT-dependent luciferase reporter activity in Jurkat T cell cultures infected with HIV-1 variants expressing nef alleles from SIVsmm-infected SMs compared to the nef defective control. The luciferase reporter activities represent the average (+/- SD) of triple infections. Similar results were obtained in two independent experiments. For clarity animal FYb was excluded from the analysis in the right panel.
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 603 607 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 398 404 <span type="species:ncbi:9606">humans</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
###xml 877 880 <span type="species:ncbi:9531">SMs</span>
###xml 1089 1094 <span type="species:ncbi:9606">human</span>
In the present study, we show that nef alleles from different lineages of SIVsmm modulate the surface expression of human CD4, CD3, CD28, MHC-I and Ii molecules, suppress T cell activation and enhance viral spread and infectivity. This result is in agreement with our previous findings showing that SIVsmm and SIVcpz nef alleles [43,69] but also those derived from SIVs that have not been found in humans [30] do not require adaptive changes to be functionally active in human cells. We did not find any significant lineage-specific differences in SIVsmm Nef function. Thus, although a larger number of nef alleles from all clades of SIVsmm must be analyzed to definitely exclude this possibility, our results suggest that lineage-specific differences in SIVsmm Nef function do not play a major role in the virological and immunological features of natural SIVsmm infection in SMs. In comparison, strain-dependent differences in Nefs ability to facilitate viral immune evasion and to promote viral spread may significantly affect the fitness and pathogenicity of SIVsmm in its natural SM, human and experimental macaque hosts.
###end p 59
###begin p 60
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 376 380 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 507 511 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1078 1080 1078 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1875 1877 1875 1877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 543 546 <span type="species:ncbi:9531">SMs</span>
###xml 890 905 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 981 996 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 1221 1224 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1229 1232 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1835 1838 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
One remarkable observation was that SIVsmm nef alleles were generally less potent in down-modulating various human receptors and in suppressing T cell activation than that of SIVmac239. This difference was not due to the fact that the bulk nef preparations contained a high frequency of inactivating point mutations, since all 24 individual proviral constructs encoded intact nef open reading frames and because the activity of the individual nef alleles recapitulated that of the bulks. Altogether, SIVsmm nef alleles from about 40 different SMs and belonging to five different lineages have been functionally analyzed to date [42,43]. The fact that SIVsmm Nefs are generally less active in modulating CD3, CD28 and CXCR4 than that of SIVmac239 suggests that the latter evolved to become more active in suppressing the migration and activation of infected T cells during its adaptation to rhesus macaques. At first view this may seem counterintuitive since SIVmac239 infection of rhesus macaques is associated with high levels of chronic T cell activation and rapid loss of CD4+ T cell loss and progression to simian AIDS [35]. It is conceivable, however, that for effective viral persistence in their respective hosts, HIV and SIV must balance the activation of virally infected T cells to levels that are high enough to ensure efficient proviral transcription but also so low that they do not cause apoptosis before the viral replication cycle is completed. The necessity to carefully adjust the responsiveness of virally infected T cells to activation to achieve this balance most likely explains why primary SIVsmm Nefs show only moderate activity in functions affecting the interaction and stimulation of T cells by APCs. The experimental macaque host reacts with much higher levels of immune activation and T cell activation to SIV infection than the natural SM host [70]. It is thus plausible that SIVsmm/SIVmac may have evolved not only to persist efficiently at high levels but also to become more active in suppressing T cell activation in macaques to compensate for the aggravated immune response in this new host.
###end p 60
###begin p 61
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 960 964 960 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1208 1212 1208 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1389 1393 1389 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1669 1671 1669 1671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1847 1855 1847 1855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1856 1858 1856 1858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 1859 1861 1859 1861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 1891 1895 1891 1895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 98 103 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 132 137 <span type="species:ncbi:9606">human</span>
###xml 193 198 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 265 268 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 273 276 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 321 326 <span type="species:ncbi:9606">human</span>
###xml 626 631 <span type="species:ncbi:9606">human</span>
###xml 710 715 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 727 732 <span type="species:ncbi:9606">human</span>
###xml 1032 1037 <span type="species:ncbi:9606">human</span>
###xml 1112 1117 <span type="species:ncbi:9606">human</span>
One limitation of the present study is that the data on SIVsmm Nef function were derived using an HIV-1-based proviral construct in human derived cells. We have previously shown, however, that HIV-1, SIVmac and SIVagm derived proviral constructs expressing various HIV and SIV nef alleles exhibited the same phenotype in human and SM PBMC [30]. Thus, the effect of Nef on receptor modulation and T cell activation is independent of the proviral context and conserved in target cells from divergent primate species. Moreover, one goal of the present study was to assess whether lineage-dependent differences in Nef function in human cells may have affected the fitness and hence the subsequent spread of SIVsmm/HIV-2 in the new human host. Lack of Nef function could potentially play a relevant role because Nef is required for effective viral persistence [32-35] and the efficiency of sexual viral transmission correlates with the viral load. Our finding that nef alleles from all five lineages of SIVsmm analyzed modulated various human receptors, suppressed T cell activation and promoted viral infectivity in human-derived cells suggests that this was most likely not the case. However, larger numbers of nef alleles from the different lineages of SIVsmm need to functionally to exclude the possibility that some (perhaps subtle) functional differences do exist. For example, L1 and L2 nef alleles usually enhanced virion infectivity more efficiently than those derived from L3. Whether or not it is just coincidence that SIVsmm L1 and L2 are more widespread and associated with higher viral loads compared to L3 in the animal cohorts housed at the YNPRC and TNPRC [21] remains to be determined. Previous results in the SIVmac/macaque model suggest that Nef-mediated enhancement of virion infectivity contributes to efficient viral replication in vivo [58,70], although the fact that the nef alleles used in these studies also differed in other functional aspects precludes definitive conclusions.
###end p 61
###begin p 62
###xml 150 152 150 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 358 360 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 613 617 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 686 690 686 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 807 809 807 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 915 917 914 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1059 1060 1058 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 1155 1157 1154 1156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1216 1220 1215 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1229 1231 1228 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1275 1279 1274 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1346 1348 1345 1347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1444 1448 1443 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 82 85 <span type="species:ncbi:9531">SMs</span>
###xml 1139 1142 <span type="species:ncbi:9531">SMs</span>
###xml 1305 1308 <span type="species:ncbi:9531">SMs</span>
Another issue that warrants further study is the previous finding that 3 out of 4 SMs infected with L5 SIVsmm strains showed a significant loss of CD4+ T cells, whereas this only observed in about 10-15% of animals infected with SIVsmm lineages 1, 2 and 3 [21,22]. Since inefficient Nef-mediated downmodulation of CD3 and MHC-I correlates with numbers of CD4+ T cells in natural SIVsmm infection [42] it was tempting to speculate that L5 Nefs may be poorly active in these functions. In the present study we did not observe a particularly low activity of L5 Nef in modulating CD3 or MHC-I. However, only three L5 nef alleles were available for functional analyses. Furthermore, the FTq nef that has not been analyzed in the previous study [42] was derived from the only SIVsmm L5 infected SM with normal CD4+ T cell counts (~850/mul) and no plasma sample was available from the animals with the lowest number of CD4+ T cells. Finally, the comparison of the functional activity of the remaining two L5 Nefs with those derived from other lineages shown in Fig. 9 is not suitable to address the question because SIVsmm L1, L2 and L3 infected SMs with low CD4+ T cell counts are strongly over-represented in this set of nef alleles [42]. The fact, that these previously examined nef alleles were derived from SMs selected based on their different CD4+ T cell counts may also explain why they are functionally more divergent than the newly analyzed nef alleles.
###end p 62
###begin p 63
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 1036 1040 1036 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1106 1108 1106 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1112 1114 1112 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 1196 1205 1196 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1238 1240 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1346 1348 1346 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 1596 1600 1596 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1733 1737 1733 1737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 139 144 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 284 289 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 458 463 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 516 519 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 548 553 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 692 697 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 747 752 <span type="species:ncbi:9606">human</span>
###xml 769 774 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 812 817 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 918 923 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 956 961 <span type="species:ncbi:9606">human</span>
###xml 1063 1068 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1088 1093 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1130 1135 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1215 1220 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1246 1251 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1304 1309 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1407 1412 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1470 1475 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1590 1595 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1721 1724 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1729 1732 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1817 1823 <span type="species:ncbi:9606">humans</span>
The fact that primary nef alleles from all lineages of SIVsmm analyzed are functional in human-derived cells suggests that Nef facilitated HIV-2 to maintain high viral loads and spread in the new human host without requiring adaptive changes. In contrast to natural SIVsmm infection, HIV-2 is associated with AIDS in a significant number of infected individuals, although it causes lower levels of immune activation and is substantially less pathogenic than HIV-1 [71,72]. Furthermore, in strict contrast to natural SIV infections, non-progressing HIV-2 infections are typically associated with low viral loads [73,74] and hence most likely also with ineffective virus transmission. In fact, HIV-2 has spread substantially less efficiently in the human population than HIV-1 and recent findings suggest that the HIV-2 epidemic is now declining [75]. Currently, too little information is available to assess how SIVsmm/HIV-2 Nef function evolved in the new human host. Preliminary data suggest, however, that the prevalence of defective nef genes may be higher in HIV-2 than in SIVsmm and HIV-1 infections [42,43,76]. Furthermore, HIV-2 Nefs are usually less active in enhancing viral replication in vitro than both HIV-1 and SIVsmm Nefs [43] and HIV-2 isolates show lower replicative fitness compared to HIV-1 isolates in infected PBMC cultures [77]. To obtain further insights into the evolution of SIVsmm/HIV-2 Nef function after zoonotic transmission and its role in HIV-2 replication and pathogenesis it will be interesting to perform a systematic and comprehensive analysis of primary HIV-2 nef alleles from infected individual who are clinically well characterized. Taken together, our current knowledge shows that SIV and HIV nef alleles are usually functionally active in cells of a new host species, such as humans or macaques. However, the fine-tuning of Nef function to allow effective viral replication and spread without causing harm to the infected host is obviously difficult to achieve.
###end p 63
###begin title 64
Conclusion
###end title 64
###begin p 65
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 847 851 847 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 1343 1346 1343 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpr</italic>
###xml 1348 1351 1348 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpx</italic>
###xml 1353 1357 1353 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpu </italic>
###xml 1361 1365 1361 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 200 205 <span type="species:ncbi:9606">human</span>
###xml 354 357 <span type="species:ncbi:9531">SMs</span>
###xml 361 367 <span type="species:ncbi:9606">humans</span>
###xml 406 411 <span type="species:ncbi:9606">human</span>
###xml 843 846 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 876 881 <span type="species:ncbi:9606">human</span>
###xml 924 929 <span type="species:ncbi:9606">human</span>
###xml 1144 1147 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Our analysis of nef alleles from different clades of SIVsmm shows that they are all capable to modulate the surface expression of various receptors and to enhance viral infectivity and replication in human derived cells. These results suggest that lack of these Nef functions was not the reason why only two of eight zoonotic transmission of SIVsmm from SMs to humans resulted in significant spread in the human population. Our finding that primary SIVsmm Nefs are generally only moderately active in functions that affect the migration of T cells and their responsiveness to stimulation most likely reflects the necessity for SIVsmm to curb T cell activation to levels that warrant effective viral replication without damaging the host immune system. Together with the results of previous studies [30,42,43,46,69], the present data show that SIV nef alleles from African non-human primate species are usually functional in human or macaque derived cells. Obviously, however, the fine-tuning of various Nef (and possibly other) functions to establish an elaborative well-balanced virus-host relationship similarly to that found in some natural SIV infections is also dependent on various host factors and seems difficult to achieve. Further studies with well characterized molecular SIVclones differing in the repertoire (e.g. the presence of vpr, vpx, vpu and nef gene) or function of their accessory genes in adapted and non-adapted monkey hosts are needed to achieve a better understanding of these complex virus-host interactions.
###end p 65
###begin title 66
Competing interests
###end title 66
###begin p 67
The authors declare that they have no competing interests.
###end p 67
###begin title 68
Authors' contributions
###end title 68
###begin p 69
Conceived and designed the experiments: GS BHH CA FK. Performed the experiments: JS HL MS. Analyzed the data: JS HL CA FK. Contributed reagents/materials/analysis tools: GS BHH CA FK. Wrote the paper: FK.
###end p 69
###begin title 70
Acknowledgements
###end title 70
###begin p 71
We thank Thomas Mertens for support, Daniela Krnavek, Martha Mayer and Kerstin Regensburger for expert technical assistance, Michel J. Tremblay for Jurkat cells stably transfected with an NFAT-dependent reporter gene vector and Ingrid Bennett for critical reading of the manuscript. This work was supported by the Wilhelm-Sander Foundation, the Deutsche Forschungsgemeinschaft, and NIH R01 grants AI067057, R01 AI065325 and P20 RR020159 (CA), and P51 RR000164 (TNPRC).
###end p 71
###begin article-title 72
###xml 17 20 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 24 35 <span type="species:ncbi:9598">chimpanzees</span>
Hybrid origin of SIV in chimpanzees
###end article-title 72
###begin article-title 73
Going wild: lessons from naturally occurring T-lymphotropic lentiviruses
###end article-title 73
###begin article-title 74
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 53 58 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Human infection by genetically diverse SIVSM-related HIV-2 in west Africa
###end article-title 74
###begin article-title 75
###xml 10 15 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 23 33 <span type="species:ncbi:9598">chimpanzee</span>
###xml 34 61 <span type="species:ncbi:37011">Pan troglodytes troglodytes</span>
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes
###end article-title 75
###begin article-title 76
AIDS as a zoonosis: scientific and public health implications
###end article-title 76
###begin article-title 77
###xml 0 29 <span type="species:ncbi:11723">Simian immunodeficiency virus</span>
###xml 56 71 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 73 88 <span type="species:ncbi:9531">Cercocebus atys</span>
###xml 171 206 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
Simian immunodeficiency virus infection in free-ranging sooty mangabeys (Cercocebus atys atys) from the Tai Forest, Cote d'Ivoire: implications for the origin of epidemic human immunodeficiency virus type 2
###end article-title 77
###begin article-title 78
###xml 16 51 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast
###end article-title 78
###begin article-title 79
###xml 9 19 <span type="species:ncbi:11709">HIV type 2</span>
###xml 53 56 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 68 78 <span type="species:ncbi:11709">HIV type 2</span>
###xml 92 102 <span type="species:ncbi:11709">HIV type 2</span>
Nigerian HIV type 2 subtype A and B from heterotypic HIV type 1 and HIV type 2 or monotypic HIV type 2 infections
###end article-title 79
###begin article-title 80
###xml 0 35 <span type="species:ncbi:11709">Human immunodeficiency virus type 2</span>
###xml 37 42 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 94 99 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 142 171 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 181 196 <span type="species:ncbi:9531">sooty mangabeys</span>
Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys
###end article-title 80
###begin article-title 81
###xml 21 56 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology
###end article-title 81
###begin article-title 82
###xml 24 29 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Identification of a new HIV-2 subtype based on phylogenetic analysis of full-length genomic sequence
###end article-title 82
###begin article-title 83
###xml 57 60 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Current concepts in AIDS pathogenesis: insights from the SIV/macaque model
###end article-title 83
###begin article-title 84
###xml 42 77 <span type="species:ncbi:11712">simian immunodeficiency virus SIVsm</span>
Detection and partial characterization of simian immunodeficiency virus SIVsm strains from bush meat samples from rural Sierra Leone
###end article-title 84
###begin article-title 85
Pathogenic diversity of simian immunodeficiency viruses
###end article-title 85
###begin article-title 86
###xml 0 3 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 9 30 <span type="species:ncbi:9540">stump-tailed macaques</span>
SIV from stump-tailed macaques: molecular characterization of a highly transmissible primate lentivirus
###end article-title 86
###begin article-title 87
###xml 34 63 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression
###end article-title 87
###begin article-title 88
###xml 20 49 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 119 134 <span type="species:ncbi:9544">rhesus macaques</span>
Specific passage of simian immunodeficiency virus from end-stage disease results in accelerated progression to AIDS in rhesus macaques
###end article-title 88
###begin article-title 89
###xml 32 37 <span type="species:ncbi:9606">human</span>
Simian retroviral infections in human beings
###end article-title 89
###begin article-title 90
###xml 22 51 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 57 72 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 93 113 <span type="species:ncbi:75566">Lophocebus aterrimus</span>
Direct inoculation of simian immunodeficiency virus from sooty mangabeys in black mangabeys (Lophocebus aterrimus): first evidence of AIDS in a heterologous African species and different pathologic outcomes of experimental infection
###end article-title 90
###begin article-title 91
###xml 59 88 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3
###end article-title 91
###begin article-title 92
###xml 43 72 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 93 108 <span type="species:ncbi:9531">sooty mangabeys</span>
Virus subtype-specific features of natural simian immunodeficiency virus SIVsmm infection in sooty mangabeys
###end article-title 92
###begin article-title 93
###xml 80 109 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 123 138 <span type="species:ncbi:9531">sooty mangabeys</span>
Correlates of preserved CD4(+) T cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys: implications for AIDS pathogenesis
###end article-title 93
###begin article-title 94
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis
###end article-title 94
###begin article-title 95
###xml 32 67 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene
###end article-title 95
###begin article-title 96
Serine phosphorylation-independent downregulation of cell-surface CD4 by nef
###end article-title 96
###begin article-title 97
###xml 4 32 <span type="species:ncbi:12721">human immunodeficiency virus</span>
The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages
###end article-title 97
###begin article-title 98
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell
###end article-title 98
###begin article-title 99
###xml 42 77 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes
###end article-title 99
###begin article-title 100
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef impairs MHC class II antigen presentation and surface expression
###end article-title 100
###begin article-title 101
###xml 97 102 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1
###end article-title 101
###begin article-title 102
Role of Nef in primate lentiviral immunopathogenesis
###end article-title 102
###begin article-title 103
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients
###end article-title 103
###begin article-title 104
###xml 42 77 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor
###end article-title 104
###begin article-title 105
###xml 90 95 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection
###end article-title 105
###begin article-title 106
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
###end article-title 106
###begin article-title 107
###xml 46 75 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence
###end article-title 107
###begin article-title 108
###xml 47 76 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Mechanisms of protection induced by attenuated simian immunodeficiency virus. IV. Protection against challenge with virus grown in autologous simian cells
###end article-title 108
###begin article-title 109
###xml 84 119 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection
###end article-title 109
###begin article-title 110
###xml 17 52 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation
###end article-title 110
###begin article-title 111
###xml 77 106 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 112 127 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 129 132 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM)
###end article-title 111
###begin article-title 112
Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys
###end article-title 112
###begin article-title 113
###xml 104 107 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Inefficient Nef-mediated downmodulation of CD3 and MHC-I correlates with loss of CD4+T cells in natural SIV infection
###end article-title 113
###begin article-title 114
###xml 8 22 <span type="species:ncbi:9531">sooty mangabey</span>
###xml 23 52 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 57 92 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
###xml 149 154 <span type="species:ncbi:9606">human</span>
Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication
###end article-title 114
###begin article-title 115
###xml 52 81 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Comprehensive analysis of nef functions selected in simian immunodeficiency virus-infected macaques
###end article-title 115
###begin article-title 116
###xml 39 67 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction
###end article-title 116
###begin article-title 117
Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses
###end article-title 117
###begin article-title 118
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
###end article-title 118
###begin article-title 119
Bayesian phylogenetic inference using DNA sequences: a Markov Chain Monte Carlo Method
###end article-title 119
###begin article-title 120
MRBAYES: Bayesian inference of phylogenetic trees
###end article-title 120
###begin article-title 121
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 20 23 <span type="species:ncbi:4456">ape</span>
Dating of the human-ape splitting by a molecular clock of mitochondrial DNA
###end article-title 121
###begin article-title 122
Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: approximate methods
###end article-title 122
###begin article-title 123
###xml 38 43 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structure - function relationships in HIV-1 Nef
###end article-title 123
###begin article-title 124
###xml 14 17 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Cutting edge: SIV Nef protein utilizes both leucine- and tyrosine-based protein sorting pathways for down-regulation of CD4
###end article-title 124
###begin article-title 125
Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes
###end article-title 125
###begin article-title 126
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Interactions of HIV-1 NEF with cellular signal transducing proteins
###end article-title 126
###begin article-title 127
###xml 70 99 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 164 179 <span type="species:ncbi:9544">rhesus macaques</span>
Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques
###end article-title 127
###begin article-title 128
###xml 11 39 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression
###end article-title 128
###begin article-title 129
###xml 115 144 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Disrupting surfaces of nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo
###end article-title 129
###begin article-title 130
Nef proteins from diverse groups of primate lentiviruses downmodulate CXCR4 to inhibit migration to the chemokine stromal derived factor 1
###end article-title 130
###begin article-title 131
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 171 200 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles
###end article-title 131
###begin article-title 132
###xml 40 45 <span type="species:ncbi:9606">human</span>
Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)
###end article-title 132
###begin article-title 133
Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement
###end article-title 133
###begin article-title 134
###xml 19 24 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Nef protein of HIV-1 associates with rafts and primes T cells for activation
###end article-title 134
###begin article-title 135
###xml 45 48 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Secreted phospholipases A(2), a new class of HIV inhibitors that block virus entry into host cells
###end article-title 135
###begin article-title 136
###xml 98 133 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1
###end article-title 136
###begin article-title 137
###xml 23 58 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
###end article-title 137
###begin article-title 138
###xml 23 58 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 151 156 <span type="species:ncbi:9606">human</span>
CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T cell depletion in human lymphoid tissue ex vivo
###end article-title 138
###begin article-title 139
###xml 44 79 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes
###end article-title 139
###begin article-title 140
###xml 18 47 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 57 68 <span type="species:ncbi:9598">chimpanzees</span>
###xml 154 159 <span type="species:ncbi:9606">human</span>
Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors
###end article-title 140
###begin article-title 141
###xml 59 88 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 122 137 <span type="species:ncbi:9544">rhesus macaques</span>
Importance of the N-distal AP-2 binding element in Nef for simian immunodeficiency virus replication and pathogenicity in rhesus macaques
###end article-title 141
###begin article-title 142
###xml 94 99 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Clinical, hematological, and immunologic cross sectional evaluation of individuals exposed to HIV-2
###end article-title 142
###begin article-title 143
###xml 50 55 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Reduced immune activation and T cell apoptosis in HIV-2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution
###end article-title 143
###begin article-title 144
###xml 60 65 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 67 72 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients
###end article-title 144
###begin article-title 145
###xml 6 34 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 36 39 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 103 108 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 113 118 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2
###end article-title 145
###begin article-title 146
###xml 17 20 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 105 110 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 115 120 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2
###end article-title 146
###begin article-title 147
###xml 30 65 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
Evidence of Nef truncation in human immunodeficiency virus type 2 infection
###end article-title 147
###begin article-title 148
###xml 60 95 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
###xml 97 102 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 122 127 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection
###end article-title 148

